Aminoacyl-tRNA Synthetases in Human Health and Disease

Overview

Journal Front Physiol

Date 2022 Nov 4

PMID 36330207

Authors

Alexandra K Turvey

Gabriella A Horvath

Andre R O Cavalcanti

Affiliations

Soon will be listed here.

Abstract

The Aminoacyl-tRNA Synthetases (aaRSs) are an evolutionarily ancient family of enzymes that catalyze the esterification reaction linking a transfer RNA (tRNA) with its cognate amino acid matching the anticodon triplet of the tRNA. Proper functioning of the aaRSs to create aminoacylated (or "charged") tRNAs is required for efficient and accurate protein synthesis. Beyond their basic canonical function in protein biosynthesis, aaRSs have a surprisingly diverse array of non-canonical functions that are actively being defined. The human genome contains 37 genes that encode unique aaRS proteins. To date, 56 human genetic diseases caused by damaging variants in aaRS genes have been described: 46 are autosomal recessive biallelic disorders and 10 are autosomal dominant monoallelic disorders. Our appreciation of human diseases caused by damaging genetic variants in the aaRSs has been greatly accelerated by the advent of next-generation sequencing, with 89% of these gene discoveries made since 2010. In addition to these genetic disorders of the aaRSs, anti-synthetase syndrome (ASSD) is a rare autoimmune inflammatory myopathy that involves the production of autoantibodies that disrupt aaRS proteins. This review provides an overview of the basic biology of aaRS proteins and describes the rapidly growing list of human diseases known to be caused by genetic variants or autoimmune targeting that affect both the canonical and non-canonical functions of these essential proteins.

Citing Articles

Strategies for detecting aminoacylation and aminoacyl-tRNA editing and in cells.

Watkins R, Kavoor A, Musier-Forsyth K Isr J Chem. 2025; 64(8-9).

PMID: 40066018 PMC: 11892019. DOI: 10.1002/ijch.202400009.

Setting the Stage for Treatment of Aminoacyl-tRNA Synthetase (ARS)1-Deficiencies: Phenotypic Characterization and a Review of Treatment Effects.

Hoytema van Konijnenburg E, Rohof J, Kok G, van Hasselt P, van Karnebeek C, Muffels I J Inherit Metab Dis. 2025; 48(2):e70017.

PMID: 40044141 PMC: 11882346. DOI: 10.1002/jimd.70017.

Structural basis for aminoacylation of cellular modified tRNALys3 by human lysyl-tRNA synthetase.

Devarkar S, Budding C, Pathirage C, Kavoor A, Herbert C, Limbach P Nucleic Acids Res. 2025; 53(5).

PMID: 40036503 PMC: 11878792. DOI: 10.1093/nar/gkaf114.

Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mA RNA Modification.

Tian S, Song Y, Guo L, Zhao H, Bai M, Miao M J Cell Mol Med. 2025; 29(1):e70344.

PMID: 39779466 PMC: 11710941. DOI: 10.1111/jcmm.70344.

Human disease-causing missense genetic variants are enriched in the evolutionarily ancient domains of the cytosolic aminoacyl-tRNA synthetase proteins.

Turvey A, Cavalcanti A IUBMB Life. 2024; 77(1):e2932.

PMID: 39710895 PMC: 11664165. DOI: 10.1002/iub.2932.

References

Mellado W, Willis D . Stressing out translation. Science. 2021; 373(6559):1089-1090. DOI: 10.1126/science.abk3261. View

Kopajtich R, Murayama K, Janecke A, Haack T, Breuer M, Knisely A . Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile Hepatopathy. Am J Hum Genet. 2016; 99(2):414-22. PMC: 4974065. DOI: 10.1016/j.ajhg.2016.05.027. View

Gotz A, Tyynismaa H, Euro L, Ellonen P, Hyotylainen T, Ojala T . Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet. 2011; 88(5):635-42. PMC: 3146718. DOI: 10.1016/j.ajhg.2011.04.006. View

Fuchs S, Schene I, Kok G, Jansen J, Nikkels P, van Gassen K . Aminoacyl-tRNA synthetase deficiencies in search of common themes. Genet Med. 2018; 21(2):319-330. PMC: 7091658. DOI: 10.1038/s41436-018-0048-y. View

Cui H, Kapur M, Diedrich J, Yates J, Ackerman S, Schimmel P . Regulation of ex-translational activities is the primary function of the multi-tRNA synthetase complex. Nucleic Acids Res. 2020; 49(7):3603-3616. PMC: 8053116. DOI: 10.1093/nar/gkaa1183. View

Bamshad M, Nickerson D, Chong J . Mendelian Gene Discovery: Fast and Furious with No End in Sight. Am J Hum Genet. 2019; 105(3):448-455. PMC: 6731362. DOI: 10.1016/j.ajhg.2019.07.011. View

Niehues S, Bussmann J, Steffes G, Erdmann I, Kohrer C, Sun L . Corrigendum: Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat Commun. 2016; 7:10497. PMC: 4736090. DOI: 10.1038/ncomms10497. View

Teunissen L, Notermans N, Franssen H, van Engelen B, Baas F, Wokke J . Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study. Arch Neurol. 2003; 60(6):823-8. DOI: 10.1001/archneur.60.6.823. View

Wakasugi K, Schimmel P . Two distinct cytokines released from a human aminoacyl-tRNA synthetase. Science. 1999; 284(5411):147-51. DOI: 10.1126/science.284.5411.147. View

10.

Scheper G, van der Klok T, van Andel R, van Berkel C, Sissler M, Smet J . Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet. 2007; 39(4):534-9. DOI: 10.1038/ng2013. View

11.

Storkebaum E, Leitao-Goncalves R, Godenschwege T, Nangle L, Mejia M, Bosmans I . Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate in Drosophila features of human Charcot-Marie-Tooth neuropathy. Proc Natl Acad Sci U S A. 2009; 106(28):11782-7. PMC: 2702257. DOI: 10.1073/pnas.0905339106. View

12.

Rodova M, Ankilova V, Safro M . Human phenylalanyl-tRNA synthetase: cloning, characterization of the deduced amino acid sequences in terms of the structural domains and coordinately regulated expression of the alpha and beta subunits in chronic myeloid leukemia cells. Biochem Biophys Res Commun. 1999; 255(3):765-73. DOI: 10.1006/bbrc.1999.0141. View

13.

Meyer-Schuman R, Antonellis A . Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum Mol Genet. 2017; 26(R2):R114-R127. PMC: 5886470. DOI: 10.1093/hmg/ddx231. View

14.

Roux C, Barcia G, Schiff M, Sissler M, Levy R, Dangouloff-Ros V . Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations. Mol Genet Metab. 2021; 133(2):222-229. DOI: 10.1016/j.ymgme.2021.04.004. View

15.

Belostotsky R, Ben-Shalom E, Rinat C, Becker-Cohen R, Feinstein S, Zeligson S . Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet. 2011; 88(2):193-200. PMC: 3035710. DOI: 10.1016/j.ajhg.2010.12.010. View

16.

Khan K, Baleanu-Gogonea C, Willard B, Gogonea V, Fox P . 3-Dimensional architecture of the human multi-tRNA synthetase complex. Nucleic Acids Res. 2020; 48(15):8740-8754. PMC: 7470956. DOI: 10.1093/nar/gkaa569. View

17.

Parikh S, Bernard G, Leventer R, van der Knaap M, Van Hove J, Pizzino A . A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies. Mol Genet Metab. 2015; 114(4):501-515. PMC: 4390485. DOI: 10.1016/j.ymgme.2014.12.434. View

18.

Kyriacou S, Deutscher M . An important role for the multienzyme aminoacyl-tRNA synthetase complex in mammalian translation and cell growth. Mol Cell. 2008; 29(4):419-27. PMC: 2273998. DOI: 10.1016/j.molcel.2007.11.038. View

19.

Crick F . Central dogma of molecular biology. Nature. 1970; 227(5258):561-3. DOI: 10.1038/227561a0. View

20.

Datt M, Sharma A . Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-tRNA synthetases. BMC Genomics. 2014; 15:1063. PMC: 4298046. DOI: 10.1186/1471-2164-15-1063. View